MYP_161060
CPE
Anticancer
▸
Cytotoxic anticancer activity
▸
Cytotoxic
Antimicrobial
Antiviral
▸
Anti-HIV
▸
Antiviral
▸
Antiviral mechanism
▸
Toxicity / Safety
▸
Cytotoxicity
▸
Cytotoxic
Venom / Toxin
▸
General toxin
▸
Cytotoxic
Standard
7 amino acids
C42H59N7O10S
Standard
CPFVFLE
854.02 Da
4.60
-1.24
-1.46
-0.1774
1.57
0.13
0.60
63.60
97.14
0.2857
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
266.43
0.80
9.0
10.0
23.0
60.0
3.0
6.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0336428
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
Cyclization
Cyclization
Bio-Activity Profile
Antimicrobial
RECORD: Rec_0384141
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
cyclic peptide architecture [Cyclic]
canonical L-amino-acid peptide [L]
Cyclization (N termini to C termini)
Cyclization (N termini to C termini)
Bio-Activity Profile
Anti-HIV-1
Fusion inhibition
inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells
115.6±6.28 μM
IC50
Mammalian: 1.2 h; Yeast: >20 h; E. coli: >10 h
Showing 2 records on this page · Page 2 of 2